Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume $4.10 -0.38 (-8.48%) As of 10:52 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Acurx Pharmaceuticals Short Interest DataAcurx Pharmaceuticals (ACXP) has a short interest of 638,200 shares, representing 2.48% of the float (the number of shares available for trading by the public). This marks a -2.95% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 141,525 shares to cover all short positions.Current Short Interest638,200 sharesPrevious Short Interest657,600 sharesChange Vs. Previous Month-2.95%Dollar Volume Sold Short$276.72 thousandShort Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2025Outstanding Shares1,540,000 sharesFloat Size25,730,000 sharesShort Percent of Float2.48%Today's Trading Volume34,170 sharesAverage Trading Volume141,525 sharesToday's Volume Vs. Average24% Short Selling Acurx Pharmaceuticals? Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACXP Short Interest Over TimeACXP Days to Cover Over TimeACXP Percentage of Float Shorted Over Time Acurx Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2025638,200 shares $276.72 thousand -3.0%2.5%0.1 $0.43 6/30/2025657,600 shares $335.90 thousand +24.7%3.2%0.1 $0.51 6/15/2025527,300 shares $160.83 thousand +78.4%2.6%0.1 $0.31 5/31/2025295,500 shares $112.97 thousand -23.0%1.5%1.6 $0.38 5/15/2025383,600 shares $143.12 thousand +8.7%1.9%1.5 $0.37 4/30/2025353,000 shares $151.79 thousand -15.7%1.8%1.5 $0.43 4/15/2025418,900 shares $159.18 thousand -11.9%2.2%1.7 $0.38 3/31/2025475,600 shares $185.48 thousand +12.2%2.5%1.3 $0.39 3/15/2025423,800 shares $195.37 thousand -6.4%2.2%1.2 $0.46 2/28/2025452,800 shares $321.26 thousand +112.2%2.7%1.3 $0.71 Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/2025213,400 shares $158.34 thousand -31.8%1.3%0.6 $0.74 1/31/2025313,100 shares $228.75 thousand -52.2%1.9%1.2 $0.73 1/15/2025655,000 shares $471.53 thousand +41.9%4.0%2.5 $0.72 12/31/2024461,600 shares $375.74 thousand -8.1%2.8%2.2 $0.81 12/15/2024502,100 shares $429.35 thousand +8.2%3.5%4 $0.86 11/30/2024463,900 shares $579.88 thousand +4.6%3.2%4.1 $1.25 11/15/2024443,700 shares $763.16 thousand -6.5%3.1%5.9 $1.72 10/31/2024474,500 shares $892.06 thousand -5.5%3.4%10.1 $1.88 10/15/2024501,900 shares $1.02 million +2.1%3.6%10.2 $2.04 9/30/2024491,700 shares $934.23 thousand +2.8%3.6%7.6 $1.90 9/15/2024478,300 shares $975.73 thousand +5.6%3.5%7.8 $2.04 8/31/2024452,800 shares $996.16 thousand +3.1%3.3%7.7 $2.20 8/15/2024439,400 shares $896.38 thousand -5.4%3.2%8.1 $2.04 7/31/2024464,300 shares $1.00 million -17.3%3.5%7.8 $2.16 7/15/2024561,200 shares $1.34 million -8.6%4.2%9.4 $2.39 6/30/2024614,100 shares $1.38 million -7.1%4.6%10.9 $2.25 6/15/2024661,200 shares $1.61 million -4.0%4.9%10.6 $2.43 5/31/2024688,400 shares $1.73 million +15.6%5.1%9.2 $2.51 5/15/2024595,600 shares $1.34 million -3.2%4.4%7.4 $2.25 4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25 4/15/2024579,100 shares $946.83 thousand +71.6%4.8%5.6 $1.64 3/31/2024337,400 shares $826.63 thousand +14.6%2.8%2 $2.45 3/15/2024294,500 shares $801.04 thousand +0.9%2.5%1.7 $2.72 2/29/2024291,900 shares $837.75 thousand -3.2%2.6%1.3 $2.87 2/15/2024301,500 shares $919.58 thousand -12.3%2.7%1.3 $3.05 1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27 1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63 12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83 12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50 11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52My shocking meeting in Washington, D.C. (Ad)After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look inside Trump’s genius master plan to create a “new” gold standard, smash the U.S. debt, and kick off a Golden Century.You can watch it right here. 11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44 10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35 10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34 9/30/202310,100 shares $15.15 thousand +50.8%0.1%0 $1.50 9/15/20236,700 shares $11.86 thousand -51.1%0.1%0.2 $1.77 8/31/202313,700 shares $26.44 thousand +95.7%0.1%0.4 $1.93 8/15/20237,000 shares $11.20 thousand -63.0%0.1%0.2 $1.60 7/31/202318,900 shares $38.37 thousand +42.1%0.2%0.7 $2.03 7/15/202313,300 shares $28.46 thousand +58.3%0.1%0.5 $2.14 6/30/20238,400 shares $22.26 thousand -27.6%0.1%0.3 $2.65 6/15/202311,600 shares $31.90 thousand +39.8%0.1%0.5 $2.75 5/31/20238,300 shares $25.73 thousand -60.9%0.1%0.3 $3.10 5/15/202321,200 shares $71.87 thousand -7.0%0.2%0.7 $3.39 4/30/202322,800 shares $68.17 thousand +4.1%0.3%0.7 $2.99 4/15/202321,900 shares $64.82 thousand -25.5%0.2%0.7 $2.96 3/31/202329,400 shares $101.72 thousand -52.8%0.3%0.9 $3.46 3/15/202362,300 shares $212.44 thousand +150.2%0.7%1.8 $3.41 2/28/202324,900 shares $82.42 thousand -33.8%0.3%0.7 $3.31 2/15/202337,600 shares $131.98 thousand +78.2%0.4%1.2 $3.51 1/31/202321,100 shares $75.96 thousand -7.9%0.2%0.7 $3.60 1/15/202322,900 shares $97.33 thousand -3.4%0.2%0.9 $4.25 12/30/202223,700 shares $94.33 thousand -18.0%0.3%1 $3.98 12/15/202228,900 shares $112.71 thousand +26.8%0.3%1.4 $3.90 11/30/202222,800 shares $72.73 thousand -1.3%0.2%1 $3.19 11/15/202223,100 shares $72.07 thousand +5.5%0.3%1 $3.12 10/31/202221,900 shares $67.45 thousand -27.2%0.2%0.8 $3.08 10/15/202230,100 shares $88.80 thousand -22.2%0.3%1.1 $2.95 9/30/202238,700 shares $116.10 thousand +45.5%0.4%1.5 $3.00 9/15/202226,600 shares $103.74 thousand +10.8%0.3%1 $3.90 8/31/202224,000 shares $83.76 thousand -34.1%0.3%0.9 $3.49 8/15/202236,400 shares $164.16 thousand -13.5%0.4%1.6 $4.51 7/31/202242,100 shares $150.72 thousand +89.6%0.5%2.1 $3.58 7/15/202222,200 shares $80.48 thousand -43.9%N/A1.4 $3.63 6/30/202239,600 shares $150.08 thousand -29.9%N/A2.5 $3.79 6/15/202256,500 shares $213.57 thousand +16.3%N/A3.2 $3.78 5/31/202248,600 shares $130.73 thousand -1.2%N/A2.8 $2.69 5/15/202249,200 shares $133.33 thousand +39.4%N/A2.7 $2.71 4/30/202235,300 shares $131.67 thousand -59.2%N/A2 $3.73 4/15/202286,600 shares $346.40 thousand -22.3%N/A3.3 $4.00 3/31/2022111,400 shares $365.39 thousand +136.5%N/A4 $3.28 3/15/202247,100 shares $175.68 thousand +9.0%N/A1.6 $3.73 2/28/202243,200 shares $157.21 thousand -53.7%N/A1.4 $3.64 2/15/202293,300 shares $376.00 thousand -4.3%N/A2.6 $4.03 1/31/202297,500 shares $405.60 thousand -28.8%N/A2.3 $4.16 1/15/2022137,000 shares $627.46 thousand -16.2%N/A3 $4.58 12/31/2021163,400 shares $706.12 thousand -6.0%N/A3.6 $4.32 12/15/2021173,800 shares $716.06 thousand +52.2%N/A2.9 $4.12 11/30/2021114,200 shares $548.16 thousand -17.1%N/A1.9 $4.80 11/15/2021137,700 shares $684.37 thousand +14.9%N/A2.2 $4.97 10/29/2021119,800 shares $599 thousand +17.7%N/A1.7 $5.00Amazon’s big Bitcoin embarrassment (Ad)Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.Watch the Bitcoin Skimming strategy here 10/15/2021101,800 shares $499.84 thousand -4.9%N/A1.2 $4.91 9/30/2021107,000 shares $549.98 thousand +11.2%N/A0.8 $5.14 9/15/202196,200 shares $485.81 thousand +24.9%N/A0.2 $5.05 8/31/202177,000 shares $398.09 thousand -35.9%N/A0.1 $5.17 8/13/2021120,100 shares $576.48 thousand No ChangeN/A0.1 $4.80 ACXP Short Interest - Frequently Asked Questions What is Acurx Pharmaceuticals' current short interest? Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 638,200 shares of ACXP short. 2.48% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest. What is a good short interest percentage for Acurx Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.48% of Acurx Pharmaceuticals' floating shares are currently sold short. Is Acurx Pharmaceuticals' short interest increasing or decreasing? Acurx Pharmaceuticals saw a drop in short interest during the month of July. As of July 15th, there was short interest totaling 638,200 shares, a drop of 3.0% from the previous total of 657,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acurx Pharmaceuticals' float size? Acurx Pharmaceuticals currently has issued a total of 1,540,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 25,730,000 shares. How does Acurx Pharmaceuticals' short interest compare to its competitors? 2.48% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acurx Pharmaceuticals: Coeptis Therapeutics Holdings, Inc. (1.84%), LAVA Therapeutics N.V. (0.40%), Sol-Gel Technologies Ltd. (2.11%), Ovid Therapeutics (1.75%), Shattuck Labs, Inc. (1.23%), Enlivex Therapeutics Ltd. (1.24%), Karyopharm Therapeutics Inc. (26.01%), Xilio Therapeutics, Inc. (18.63%), Rani Therapeutics Holdings, Inc. (29.83%), Mersana Therapeutics, Inc. (158.72%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks. What does it mean to sell short Acurx Pharmaceuticals stock? Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acurx Pharmaceuticals? A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further. How often is Acurx Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is July, 15 2025. More Short Interest Resources from MarketBeat Related Companies Coeptis Therapeutics Short Interest LAVA Therapeutics Short Interest Sol-Gel Technologies Short Interest Ovid Therapeutics Short Interest Shattuck Labs Short Interest Enlivex Therapeutics Short Interest Karyopharm Therapeutics Short Interest Xilio Therapeutics Short Interest Rani Therapeutics Short Interest Mersana Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACXP) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access